ADVERSE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PEDIATRICS: CASE SERIES ACCORDING TO THE DOCTOR REPORTS IN REPUBLIC OF CRIMEA THROUGH 2010 TO 2018

2021-05-16T13:29:39+03:00

DOI: 10.15690/vsp.v18i3.2032 Background. Nonsteroidal anti-inflammatory drugs safety profile (NSAIDs) is well-studied in clinical trials. Meanwhile, the monitoring of adverse effects (AEs) of this drug class and analysis of AEs structure in pediatrics is essential. Our aim was to study AEs related to NSAIDs in children. Methods. Retrospective analysis of doctor reports about AEs associated with drugs from N02B and M01A [...]

ADVERSE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PEDIATRICS: CASE SERIES ACCORDING TO THE DOCTOR REPORTS IN REPUBLIC OF CRIMEA THROUGH 2010 TO 20182021-05-16T13:29:39+03:00

ASSESSMENT OF PHARMACOVIGILANCE REPORTING IN RUSSIA

2021-05-16T13:23:07+03:00

Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, V. K. Lepakhin,A. E. Krasheninnikov, E. V. Shubnikova The risk-based approach to pharmacovigilance control implemented in Russia since January 1, 2018 increases the responsibility of manufacturers and developers of medicines. The purpose of the work is to assess the system of Express reporting and Periodic reporting [...]

ASSESSMENT OF PHARMACOVIGILANCE REPORTING IN RUSSIA2021-05-16T13:23:07+03:00

ANALYSIS OF ADVERSE REACTIONS OF ANTIHYPERTENSIVE DRUGS REGISTERED IN THE REPUBLIC OF CRIMEA FOR THE PERIOD 2011-2016

2021-05-16T01:05:25+03:00

The aim of study was to analyze and investigate the severity of adverse reactions (AR) on drugs used for arterial hypertension treatment in patients living in the Republic of Crimea for the period 2011—2016.Materials and methods. We studied notification cards about AR registered in the regional database of spontaneous messages ARCADe. We analyzed 211 notification cards about AR in [...]

ANALYSIS OF ADVERSE REACTIONS OF ANTIHYPERTENSIVE DRUGS REGISTERED IN THE REPUBLIC OF CRIMEA FOR THE PERIOD 2011-20162021-05-16T01:05:25+03:00

ERYTHROMYCIN: SAFETY ISSUES

2021-05-16T00:48:26+03:00

Macrolide antimicrobials are widely used for the treatment of variety of community-acquired bacterial infections. This paper is aimed to review the data on the safety issues of erythromycin. The main attention is paid to the studies on erythromycin prokinetic properties, cardiotoxicity and fetotoxicity. Full version

ERYTHROMYCIN: SAFETY ISSUES2021-05-16T00:48:26+03:00
Go to Top